π MHRA approves vimseltinib for use in adult patients with tenosynovial giant cell tumour (TGCT) when it impacts movement or where surgery is not an option.Β
The first approval in the UK! So exciting! Hereβs hoping for a favorable NICE decision next π€π»ππ»
https://t.co/z4QZbcXrGJ
β° Just 1οΈβ£ week to go!
Exciting advances in TGCT research, you won't want to miss this opportunity to hear the latest from Dr. Dale Shepard.
π Advancements in TGCT
π August 5
π 6:00 PM ET
π Register today: https://t.co/cCXwg5PYef
You donβt have to climb to the top of the Empire State Building to learn more about #TGCT this TGCT & Sarcoma Awareness Month!
Learn more to today at https://t.co/JMTmeUjcu9
We are honored to share we will be presenting at the 23rd General Meeting of the #ISOLS conference in Vienna π¦πΉ , on Sept 26.
Check it out:
π Session 3.13: TGCTs
ποΈ September 26, 2026
β° 10:00β11:00 AM CEST
π Vienna, Austria
ποΈπ¦ Itβs #Sarcoma & #TGCT Awareness Month!
Have you ever wondered:
β What is sarcoma?
β What is TGCT?
β Why is TGCT often treated in oncology centers?
β How are TGCT and sarcoma similar and how are they different? (Hint: TGCT is not cancerous!)
Weβve got you covered! π¨
@stern_sydney was part of a mini-documentary about her journey living with #TGCT/#PVNS. The video follows her experience as a patient, educational journey, and how those experiences ultimately led to creating TGCT Support π₯
Living with a rare disease https://t.co/6wkVXwxjxT
Check out our podcast with our first-ever medical oncologist, @ShepardDale, as he discusses shared decision-making and treatment expectations in #TGCT
Spotify:
https://t.co/RnPXNFXbnP
Apple Podcast:
https://t.co/wEPH2IEYuN
We are headed to βοΈ Chicago for the American Society of Clinical Oncology (ASCO) annual conference! #ASCO annual conference is the largest oncology conference in the world with over 50,000 attendees ππ we canβt wait to discuss #TGCT, stay tuned for more updates!
π’ In this interview, Dr Stern (Head of @TGCTSupportorg Programs) discusses how advances in CSF1-targeted therapies are reshaping the treatment landscape, alongside the continued importance of multidisciplinary care and earlier specialist referral.
Read: https://t.co/HvSznFMOQ0
We are so excited to announce that we are presenting at the 23rd International Society of Limb Salvage (#ISOLS) annual conference in Vienna, Austria π¦πΉ π£ This is our FIRST talk at an orthopedic conference and we are honored to amplify the pts voice in research π¬
Stay tuned!
We are 1 MONTH away from our #TGCT Day of Learning (TDOL) conference at LUMC in π³π± (May 08)! Our agenda is jam packed with talks from experts and moments to connect with pts living with TGCT.
registered to attend the free day event, go toπππ
https://t.co/8Q7azNBJ32
Weβre proud to share the UK TGCT Consensus Guidelines are now live on Bone & Joint Open, alongside a patient-friendly version on our site.
Thank you to @BoneJointOpen and all the authors!
Medical: https://t.co/WXHgqNe8zXβ¨Patient: https://t.co/y7sAGQaZvb
A pt with #TGCT in our community, Timo, presented his experience to amplify the voice of patients at a symposium @ @myESMO Sarcoma & Rare Cancers conference in Luganoπ¨π! Our community is dedicated to spreading awareness among clinicians. πͺπ»πͺπ»πͺπ»